Program News
News and stories about the UNC Lineberger Cellular Immunotherapy Program
-
Transformational $20 million commitment will support UNC Lineberger’s Cellular Immunotherapy Program
This gift will fuel the next generation of cancer treatments, supporting all aspects of the UNC Lineberger Cellular Immunotherapy Program with an emphasis on clinical trials, expansion of the cellular therapeutics facility, and faculty recruitment and retention.
-
UNC researchers create more effective, less toxic immunotherapy to combat blood cancer
Gianpietro Dotti, MD, Paul Armistead, MD, PhD, and colleagues have created a new cellular immunotherapy that targets acute myeloid leukemia (AML) cells without impacting normal blood production, which is one of the major challenges associated with AML treatment.
-
UNC Lineberger’s Advanced Cellular Therapeutics Facility earns accreditation
The Foundation for the Accreditation of Cellular Therapy awarded accreditation without any deficiency citations to UNC Lineberger’s Advanced Cellular Therapeutics Facility.
-
Three drug cocktail shows potential to boost CAR-T cancer therapy
Gianpietro Dotti, MD, and colleagues report in Nature Immunology they have identified a cocktail of three different drugs that can be used to generate more robust CAR-Ts to fight cancer.
-
Serody and Yeh honored with Battle Distinguished Cancer Research Award
Jonathan Serody, MD, and Jen Jen Yeh, MD, were named the 2023 recipients of the Hyman L. Battle Distinguished Cancer Research Award, recognizing their significant scientific achievements.
-
Immune cell transformation can influence stem cell transplant success in cancer patients
Jonathan Serody, MD, Ian Davis, MD, PhD, and colleagues report ILC2s can change functions after a patient receives stem cells, thereby preventing a healthy rebuilding of the immune system.
-
Curated cancer care
UNC Lineberger researchers are using CAR-T to create better and personalized cancer treatments in one of the largest cell therapy facilities on the East Coast.
-
Thomas C. Shea Clinical Cancer Symposium brings together national leaders in blood cancers
The inaugural symposium featured talks on adoptive cellular therapy for lymphoid malignancies and novel approaches for the treatment of acute myeloid leukemia, myelodysplastic syndromes and myeloproliferative neoplasms.